Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
V Boldescu, MAM Behnam, N Vasilakis… - Nature Reviews Drug …, 2017 - nature.com
Infections with flaviviruses, such as dengue, West Nile virus and the recently re-emerging
Zika virus, are an increasing and probably lasting global risk. This Review summarizes and …
Zika virus, are an increasing and probably lasting global risk. This Review summarizes and …
SF1 and SF2 helicases: family matters
ME Fairman-Williams, UP Guenther… - Current opinion in …, 2010 - Elsevier
Helicases of the superfamily (SF) 1 and 2 are involved in virtually all aspects of RNA and
DNA metabolism. SF1 and SF2 helicases share a catalytic core with high structural …
DNA metabolism. SF1 and SF2 helicases share a catalytic core with high structural …
Conventional and unconventional mechanisms for capping viral mRNA
In the eukaryotic cell, capping of mRNA 5′ ends is an essential structural modification that
allows efficient mRNA translation, directs pre-mRNA splicing and mRNA export from the …
allows efficient mRNA translation, directs pre-mRNA splicing and mRNA export from the …
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
E Mastrangelo, M Pezzullo… - Journal of …, 2012 - academic.oup.com
Objectives Infection with yellow fever virus (YFV), the prototypic mosquito-borne flavivirus,
causes severe febrile disease with haemorrhage, multi-organ failure and a high mortality …
causes severe febrile disease with haemorrhage, multi-organ failure and a high mortality …
The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development
The flavivirus NS3 protein is associated with the endoplasmic reticulum membrane via its
close interaction with the central hydrophilic region of the NS2B integral membrane protein …
close interaction with the central hydrophilic region of the NS2B integral membrane protein …
Current trends and limitations in dengue antiviral research
JO Obi, H Gutiérrez-Barbosa, JV Chua… - Tropical Medicine and …, 2021 - mdpi.com
Dengue is the most prevalent arthropod-borne viral disease worldwide and affects
approximately 2.5 billion people living in over 100 countries. Increasing geographic …
approximately 2.5 billion people living in over 100 countries. Increasing geographic …
Ten years of dengue drug discovery: progress and prospects
To combat neglected diseases, the Novartis Institute of Tropical Diseases (NITD) was
founded in 2002 through private–public funding from Novartis and the Singapore Economic …
founded in 2002 through private–public funding from Novartis and the Singapore Economic …
Structural insights into RNA recognition by RIG-I
Intracellular RIG-I-like receptors (RLRs, including RIG-I, MDA-5, and LGP2) recognize viral
RNAs as pathogen-associated molecular patterns (PAMPs) and initiate an antiviral immune …
RNAs as pathogen-associated molecular patterns (PAMPs) and initiate an antiviral immune …
[HTML][HTML] Structure and functionality in flavivirus NS-proteins: perspectives for drug design
M Bollati, K Alvarez, R Assenberg, C Baronti, B Canard… - Antiviral research, 2010 - Elsevier
Flaviviridae are small enveloped viruses hosting a positive-sense single-stranded RNA
genome. Besides yellow fever virus, a landmark case in the history of virology, members of …
genome. Besides yellow fever virus, a landmark case in the history of virology, members of …
Molecular mechanisms of antiviral agents against dengue virus
Dengue is a major global health threat causing 390 million dengue infections and 25,000
deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of …
deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of …